Octanoic Acid Suppresses Harmaline-Induced Tremor in Mouse Model of Essential Tremor

被引:0
|
作者
Fatta B. Nahab
Adrian Handforth
Tyler Brown
Christopher Shin
Arnulfo Quesada
Chuanhui Dong
Dietrich Haubenberger
Mark Hallett
机构
[1] University of Miami Miller School of Medicine,Department of Neurology
[2] Neurology Service,Research Service, Veterans Affairs Greater Los Angeles Healthcare System, and Department of Neurobiology, David Geffen School of Medicine
[3] Veterans Affairs Greater Los Angeles Healthcare System,Department of Neurology
[4] Research Service,undefined
[5] Veterans Affairs Greater Los Angeles Healthcare System,undefined
[6] University of California at Los Angeles,undefined
[7] Medical University of Vienna,undefined
[8] Human Motor Control Section,undefined
[9] Medical Neurology Branch,undefined
[10] NINDS/NIH,undefined
来源
Neurotherapeutics | 2012年 / 9卷
关键词
1-octanol; Octanoic acid; Essential tremor; Harmaline; Therapeutics;
D O I
暂无
中图分类号
学科分类号
摘要
Recent work exploring the use of high-molecular weight alcohols to treat essential tremor (ET) has identified octanoic acid as a potential novel tremor-suppressing agent. We used an established harmaline-based mouse model of ET to compare tremor suppression by 1-octanol and octanoic acid. The dose-related effect on digitized motion power within the tremor bandwidth as a fraction of overall motion power was analyzed. Both 1-octanol and octanoic acid provided significant reductions in harmaline tremor. An 8-carbon alkyl alcohol and carboxylic acid each suppress tremor in a pre-clinical mouse model of ET. Further studies are warranted to determine the safety and efficacy of such agents in humans with ET.
引用
收藏
页码:635 / 638
页数:3
相关论文
共 50 条
  • [1] Octanoic Acid Suppresses Harmaline-Induced Tremor in Mouse Model of Essential Tremor
    Nahab, Fatta B.
    Handforth, Adrian
    Brown, Tyler
    Shin, Christopher
    Quesada, Arnulfo
    Dong, Chuanhui
    Haubenberger, Dietrich
    Hallett, Mark
    [J]. NEUROTHERAPEUTICS, 2012, 9 (03) : 635 - 638
  • [2] Development of Harmaline-induced Tremor in a Swine Model
    Lee, Jihyun
    Kim, Inyong
    Lee, Jeyeon
    Knight, Emily
    Cheng, Lei
    Kang, Shin Il
    Jang, Dong Pyo
    Chang, Su-Youne
    [J]. TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2018, 8
  • [3] Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications
    Martin, FC
    Le, AT
    Handforth, A
    [J]. MOVEMENT DISORDERS, 2005, 20 (03) : 298 - 305
  • [4] Exacerbation of harmaline-induced tremor by imipramine
    Arshaduddin, M
    Kadasah, S
    Al Deeb, S
    Al Moutaery, K
    Tariq, M
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 81 (01) : 9 - 14
  • [5] Erythropoietin ameliorates harmaline-induced essential tremor and cognition disturbances
    Mohammadi, Fatemeh
    Esfahlani, Mohsen Abedini
    Shabani, Mohammad
    [J]. NEUROSCIENCE LETTERS, 2019, 704 : 153 - 158
  • [6] Apomorphine enhances harmaline-induced tremor in rats
    Ossowska, Krystyna
    Glowacka, Urszula
    Kosmowska, Barbara
    Wardas, Jadwiga
    [J]. PHARMACOLOGICAL REPORTS, 2015, 67 (03) : 435 - 441
  • [7] Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor
    Martin, Fredricka C.
    Handforth, Adrian
    [J]. MOVEMENT DISORDERS, 2006, 21 (10) : 1641 - 1649
  • [8] The effect of memantine in harmaline-induced tremor and neurodegeneration
    Iseri, Pervin K.
    Karson, Ayse
    Gullu, Kemal M.
    Akman, Ozlem
    Kokturk, Sibel
    Yardymoglu, Melda
    Erturk, Sarp
    Ates, Nurbay
    [J]. NEUROPHARMACOLOGY, 2011, 61 (04) : 715 - 723
  • [9] Apomorphine enhances harmaline-induced tremor in rats
    Krystyna Ossowska
    Urszula Głowacka
    Barbara Kosmowska
    Jadwiga Wardas
    [J]. Pharmacological Reports, 2015, 67 : 435 - 441
  • [10] NEUROPHYSIOLOGICAL STUDIES OF HARMALINE-INDUCED TREMOR IN CAT
    LAMARRE, Y
    MERCIER, L
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1971, 49 (12) : 1049 - &